Jurgens MS, Jacobs JW, and Bijlsma JW
By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs, forcing Americans to pay sky-high prices for medicines they rely on, - FTC Chair Lina Khan Mounjaro / Zepbound (tirzepatide) Tirzepatide is newer, so the patents are protected into the late 2030s or 2040s, depending on how many extensions or additional patents Eli Lilly has secured
"I know lots of stories of social media pushing weight loss ads to small children watching YouTube [or] amplifying content to people who are already struggling with disordered eating." Calls for 'stronger safeguards' and 'greater accountability' for GLP-1 access At its peak in June 2024, Ozempic-maker Novo Nordisk was worth as much as $US615 billion ($940.40 billion)
Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein
But interest isn't evidence
Zhuang Y, Yang X, Li Y, Chen Y, Peng X, Yu L, et al
